522.1260—Lincomycin.
(a) Specifications.
Each milliliter of solution contains lincomycin hydrochloride monohydrate equivalent to:
(b) Sponsors.
See sponsors in § 510.600(c) of this chapter for uses as in paragraph (e) of this section.
(1)
No. 000009 for use of concentrations in paragraph (a)(1) of this section as in paragraph (e) of this section.
(2)
Nos. 058005 and 059130 for use of concentrations in paragraph (a)(2) of this section as in paragraph (e)(2) of this section.
(3)
No. 046573 for use of concentration in paragraph (a)(3) of this section as in paragraph (e)(2) of this section.
(4)
No. 061623 for use of concentrations in paragraph (a)(4) of this section as in paragraph (e)(2) of this section.
(c) Special considerations.
When common labeling for use of the drug in dogs, cats, and swine is included with the drug, all such uses are subject to the labeling requirements of § 201.105 of this chapter.
(1) Dogs and cats—
(i) Amount.
5 mg per pound (/lb) of body weight twice daily or 10 mg/lb body weight once daily by intramuscular injection; 5 to 10 mg/lb body weight one or two times daily by slow intravenous injection.
(ii) Indications for use.
Infections caused by Gram-positive organisms, particularly streptococci and staphylococci.
(iii) Limitations.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.